Bridge Neurotech
PrivateLast Round
Seed
Oct 7, 2026
Total Funding Raised
$13.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Bridge Neurotech operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Seed round in October 2026.
Bridge Neurotech is a healthcare technology company developing a non-invasive brain-computer interface platform that uses functional ultrasound imaging and AI-based neural decoding to image and interpret brain activity.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bridge Neurotech Comparables
Compare Bridge Neurotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merge Labs | 89% | |
| CoMind | 79% | |
| Kernel | 74% |
For institutional investors. Book with your work email.
Bridge Neurotech Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Bridge Neurotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Treehub | Seed |
| re.Mind Capital | Seed |
| General Catalyst | Seed |
| Sunflower Capital | Seed |
| Position Ventures | Seed |
| Oxford Seed Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2026
$14M raised with participation from General Catalyst.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 12, 2026
In Oct '26, Bridge Neurotech plans to build a wearable brain-computer interface that uses ultrasound.
- receives_financingOct 7, 2026
Bridge Neurotech receives $13.5M in funding from General Catalyst, reMind Capital, Sunflower Capital, and Scott Sandell on Oct 7th '26 to develop a no-implant ultrasound brain-computer interface in United States.
- is_developingOct 7, 2026
Bridge Neurotech is developing fUSI to image brain activity through the skull and uses AI models to decode the signals; its first human study is enrolling in California, and it has a research deal with Butterfly Network, on Oct 7th '26.
- identified_as_competitor_ofOct 7, 2026
Bridge Neurotech launches with plans to build a wearable, non-invasive ultrasound-based brain-computer interface and positions itself as a direct competitor to Merge in the brain-computer interface market, according to Wired, on Oct 7th '26.
- partners_withOct 6, 2026
On Oct 6th '26, Bridge Neurotech partners with Butterfly Network, Inc. to build a fully non-invasive brain-computer interface, with Bridge Neurotech licensing Butterfly Network, Inc.'s Ultrasound-on-Chip technology to read brain activity without surgery or implants.
For institutional investors. Book with your work email.
Bridge Neurotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bridge Neurotech's valuation, stock price, and market status.
Is Bridge Neurotech a public or private company?
Bridge Neurotech is a private company.
What is the current stock price of Bridge Neurotech?
Bridge Neurotech is a private company, so its shares have no public market price. Caplight tracks Bridge Neurotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bridge Neurotech worth (valuation)?
Valuation information for Bridge Neurotech is not publicly available.
Can I buy Bridge Neurotech stock?
Bridge Neurotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bridge Neurotech's last funding round?
Bridge Neurotech's most recent funding round was Seed on October 7, 2026.
Who are the main investors in Bridge Neurotech?
Key investors in Bridge Neurotech include Treehub, re.Mind Capital, General Catalyst, Sunflower Capital, Position Ventures.
Will Bridge Neurotech IPO soon?
No public IPO plans have been announced for Bridge Neurotech.
How can I track Bridge Neurotech secondary market activity?
Caplight tracks bids, offers, and trades in Bridge Neurotech's shares on secondary markets.